We have therefore determined the growth characteristics and replicative capability of fibroblasts from several progeroid syndromes and investigated the role played by p38 MAP kinase, using a combination of molecular profiling and small molecule inhibitor use. The gene discussed is MAPK14; the disease is progeroid syndrome.